WHALEROCK POINT PARTNERS, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
WHALEROCK POINT PARTNERS, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$367,000
+282.3%
84,900
+162.0%
0.15%
+265.9%
Q4 2014$96,000
-4.0%
32,400
+6.6%
0.04%
-8.9%
Q3 2014$100,00030,4000.04%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders